Tectonic Therapeutic (TECX) Current Assets (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Current Assets of $239.9 million for Q1 2026, down 22.53% year-over-year from $309.6 million in Q1 2025, and down 6.79% quarter-over-quarter from $257.4 million in Q4 2025.
Tectonic Therapeutic (TECX) Current Assets (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Current Assets for 10 consecutive years, with $239.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 22.53% year-over-year to $239.9 million; the TTM figure through Mar 2026 stood at $239.9 million (down 22.53% YoY), while the FY2025 annual figure was $257.4 million, up 75.24% from the prior year.
- Current Assets eased to $239.9 million in Q1 2026 per TECX's latest filing, from $257.4 million in the prior quarter.
- Across five years, Current Assets topped out at $309.6 million in Q1 2025 and bottomed at $30.9 million in Q4 2023.
- Historically, Current Assets has averaged $167.4 million across 5 years, with a median of $146.9 million in 2024.
- Annual changes were most pronounced in 2023 — Current Assets sank 69.1% — and 2024, when it soared 375.51%.
- Tectonic Therapeutic's Current Assets stood at $100.0 million in 2022, then tumbled by 69.1% to $30.9 million in 2023, then surged by 375.51% to $146.9 million in 2024, then jumped by 75.24% to $257.4 million in 2025, then slipped by 6.79% to $239.9 million in 2026.
- Business Quant data shows TECX's Current Assets at $239.9 million in Q1 2026, $257.4 million in Q4 2025, and $273.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 231.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 231.10 Mn |
| Mar 31, 2026 | 239.89 Mn |
| Dec 31, 2025 | 257.36 Mn |
| Sep 30, 2025 | 273.24 Mn |
| Jun 30, 2025 | 290.85 Mn |
| Mar 31, 2025 | 309.64 Mn |
| Dec 31, 2024 | 146.86 Mn |
| Sep 30, 2024 | 162.60 Mn |
| Jun 30, 2024 | 187.39 Mn |
| Mar 31, 2024 | 91.84 Mn |
| Dec 31, 2023 | 30.88 Mn |
| Sep 30, 2023 | 109.17 Mn |
| Jun 30, 2023 | 128.84 Mn |
| Mar 31, 2023 | 77.25 Mn |
| Dec 31, 2022 | 99.96 Mn |
| Sep 30, 2022 | 126.23 Mn |
| Jun 30, 2022 | 142.08 Mn |
| Mar 31, 2022 | 170.92 Mn |
| Dec 31, 2021 | 199.15 Mn |
| Sep 30, 2021 | 211.66 Mn |